The impact of prior therapies on outcomes with trifluridine/tipiracil (FTD/TPI) in the phase III TAGS trial.

Shitara, K; George, B; Taieb, J; Sundar, R; Fakih, M; Makris, L; Benhadji, KA; Ghidini, M

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (3):